288 related articles for article (PubMed ID: 33347507)
1. Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
Migita K; Nakamura M; Aiba Y; Kozuru H; Abiru S; Komori A; Fujita Y; Temmoku J; Asano T; Sato S; Furuya M; Naganuma A; Yoshizawa K; Shimada M; Ario K; Mannami T; Kohno H; Kaneyoshi T; Komura T; Ohira H; Yatsuhashi H
PLoS One; 2020; 15(12):e0238540. PubMed ID: 33347507
[TBL] [Abstract][Full Text] [Related]
2. Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
Matsuoka N; Kozuru H; Koga T; Abiru S; Yamasaki K; Komori A; Fujita Y; Tenmoku J; Asano T; Sato S; Suzuki E; Furuya M; Kobayashi H; Watanabe H; Naganuma A; Yoshizawa K; Shimada M; Ario K; Yamashita H; Kohno H; Kaneyoshi T; Nakamura M; Furukawa H; Takahashi A; Kawakami A; Ohira H; Yatsuhashi H; Migita K
Medicine (Baltimore); 2019 Aug; 98(35):e16924. PubMed ID: 31464928
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis.
Migita K; Horai Y; Kozuru H; Koga T; Abiru S; Yamasaki K; Komori A; Fujita Y; Asano T; Sato S; Suzuki E; Matsuoka N; Kobayashi H; Watanabe H; Naganuma A; Naeshiro N; Yoshizawa K; Ohta H; Sakai H; Shimada M; Nishimura H; Tomizawa M; Ario K; Yamashita H; Kamitsukasa H; Kohno H; Nakamura M; Furukawa H; Takahashi A; Kawakami A; Ohira H; Yastuhashi H
Medicine (Baltimore); 2018 Dec; 97(50):e13450. PubMed ID: 30557999
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum BAFF levels in patients with autoimmune hepatitis.
Migita K; Abiru S; Maeda Y; Nakamura M; Komori A; Ito M; Fujiwara S; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Hum Immunol; 2007 Jul; 68(7):586-91. PubMed ID: 17584580
[TBL] [Abstract][Full Text] [Related]
5. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
[TBL] [Abstract][Full Text] [Related]
6. Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus.
Asano T; Matsuoka N; Fujita Y; Matsumoto H; Temmoku J; Yashiro-Furuya M; Sato S; Suzuki E; Kobayashi H; Watanabe H; Migita K
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33167436
[TBL] [Abstract][Full Text] [Related]
7. Overlap of concurrent extrahepatic autoimmune diseases is associated with milder disease severity of newly diagnosed autoimmune hepatitis.
Mühling T; Rohrbach H; Schepp W; Gundling F
Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):21-27. PubMed ID: 32830050
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
9. Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C.
Nakamura K; Yoneda M; Takamoto S; Nakade Y; Yokohama S; Tamori K; Aso K; Matui T; Sato Y; Aoshima M; Makino I
J Gastroenterol Hepatol; 1999 May; 14(5):413-8. PubMed ID: 10355503
[TBL] [Abstract][Full Text] [Related]
10. The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury.
Seike T; Komura T; Shimizu Y; Omura H; Kumai T; Kagaya T; Ohta H; Kawashima A; Harada K; Kaneko S; Unoura M
Intern Med; 2020 Jul; 59(13):1581-1588. PubMed ID: 32269188
[TBL] [Abstract][Full Text] [Related]
11. Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis.
Schultheiß C; Steinmann S; Willscher E; Paschold L; Lohse AW; Binder M
Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37102762
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.
Amin K; Rasool AH; Hattem A; Al-Karboly TA; Taher TE; Bystrom J
World J Gastroenterol; 2017 Feb; 23(8):1345-1352. PubMed ID: 28293081
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis.
Arinaga-Hino T; Ide T; Akiba J; Suzuki H; Kuwahara R; Amano K; Kawaguchi T; Sano T; Inoue E; Koga H; Mitsuyama K; Koga Y; Torimura T
Sci Rep; 2022 May; 12(1):8759. PubMed ID: 35610317
[TBL] [Abstract][Full Text] [Related]
14. Tim-3 suppresses autoimmune hepatitis via the p38/MKP-1 pathway in Th17 cells.
Wu H; Tang S; Zhou M; Xue J; Yu Z; Zhu J
FEBS Open Bio; 2021 May; 11(5):1406-1416. PubMed ID: 33728805
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
Migita K; Komori A; Kozuru H; Jiuchi Y; Nakamura M; Yasunami M; Furukawa H; Abiru S; Yamasaki K; Nagaoka S; Hashimoto S; Bekki S; Kamitsukasa H; Nakamura Y; Ohta H; Shimada M; Takahashi H; Mita E; Hijioka T; Yamashita H; Kouno H; Nakamuta M; Ario K; Muro T; Sakai H; Sugi K; Nishimura H; Yoshizawa K; Sato T; Naganuma A; Komatsu T; Oohara Y; Makita F; Tomizawa M; Yatsuhashi H
PLoS One; 2015; 10(11):e0136908. PubMed ID: 26575387
[TBL] [Abstract][Full Text] [Related]
16. Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection.
Li F; Li N; Sang J; Fan X; Deng H; Zhang X; Han Q; Lv Y; Liu Z
Cancer Manag Res; 2018; 10():941-951. PubMed ID: 29760564
[TBL] [Abstract][Full Text] [Related]
17. [Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C].
Pavić S; Simonović J; Boricić I; Svirtlih N
Srp Arh Celok Lek; 2003; 131(11-12):437-42. PubMed ID: 15114784
[TBL] [Abstract][Full Text] [Related]
18. [Change in Serum Levels of New Hepatic Fibrosis Marker "Mac-2 Binding Protein Glycosylation isomer (M2BPGi)" in Patients with Chronic Hepatitis C during the Treatment of Pegylated Interferon and Ribavirin].
Ishida H; Suetsugu A; Nakamura M; Tauchi R; Nakayama J; Katano Y; Shirakami Y; Furuta N; Ito H; Seishima M
Rinsho Byori; 2015 Aug; 63(8):901-6. PubMed ID: 26638424
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of IgG4-associated autoimmune hepatitis.
Chung H; Watanabe T; Kudo M; Maenishi O; Wakatsuki Y; Chiba T
Liver Int; 2010 Feb; 30(2):222-31. PubMed ID: 19650840
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of checkpoint molecules in patients with adult Still's disease.
Fujita Y; Asano T; Matsumoto H; Matsuoka N; Temmoku J; Sato S; Furuya MY; Suzuki E; Watanabe H; Koga T; Kawakami A; Migita K
Arthritis Res Ther; 2020 Jul; 22(1):174. PubMed ID: 32698838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
